VOLITIONRX LTD - Common Stock, par value $0.001 per share (VNRX)

Q3 2015 13F Holders as of 9/30/2015

Type / Class: Equity / Common Stock, par value $0.001 per share
Shares outstanding: 104M
Number of holders: 8
Total 13F shares, excl. options: 948K
Shares change: +93.2K
Total reported value, excl. options: $4.25M
Value change: +$430K
Number of buys: 6
Number of sells: -2
Price: $4.46

Significant Holders of VOLITIONRX LTD - Common Stock, par value $0.001 per share (VNRX) as of Q3 2015

10 filings reported holding VNRX - VOLITIONRX LTD - Common Stock, par value $0.001 per share as of Q3 2015.
VOLITIONRX LTD - Common Stock, par value $0.001 per share (VNRX) has 8 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 948K shares of 104M outstanding shares and own 0.92% of the company stock.
Largest 10 shareholders include Southpoint Capital Advisors LP (800K shares), GOLDMAN SACHS GROUP INC (45.9K shares), MILLENNIUM MANAGEMENT LLC (26.9K shares), MORGAN STANLEY (26K shares), GARRISON BRADFORD & ASSOCIATES INC (15.5K shares), KCG Holdings, Inc. (15K shares), Bank of New York Mellon Corp (10.3K shares), UBS Group AG (8.55K shares), CREDIT SUISSE AG/ (0 shares), and Commerzbank Aktiengesellschaft /FI (0 shares).
This table shows the top 8 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

Investor	Option	Weight %	Change %	Value $	* Price $	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.